Evidence map›Paper›PMID 30835466›Full record

ArticleJournal of chemical information and modeling2019

DAKB-GPCRs: An Integrated Computational Platform for Drug Abuse Related GPCRs.

Maozi Chen, Yankang Jing, Lirong Wang, Zhiwei Feng, Xiang-Qun Xie

Open access · greenAbstract read
In one paragraph

Article in Journal of chemical information and modeling, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. IsAb: a computational protocol for antibody design.Briefings in bioinformatics · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Xie2-64, a novel CBNeuropharmacology · 2020
    Article
  12. Article
  13. Article
  14. Insight intoACS omega · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maozi ChenDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center , School of Pharmacy , Pittsburgh , Pennsylvania 15261 , United States.
Yankang JingDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center , School of Pharmacy , Pittsburgh , Pennsylvania 15261 , United States.
Lirong WangDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center , School of Pharmacy , Pittsburgh , Pennsylvania 15261 , United States.
Zhiwei FengDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center , School of Pharmacy , Pittsburgh , Pennsylvania 15261 , United States.
Xiang-Qun XieDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center , School of Pharmacy , Pittsburgh , Pennsylvania 15261 , United States.ORCID 0000-0002-6881-6175
National Institute on Drug Abuse · US

Funding

NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR)P30DA035778 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAHAR, IVET, XIE, XIANG-QUN · 2014 to 2018
$5.4M
Structure/Function of the CB2 Receptor Binding and G-protein Recognition PocketsR01DA025612 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIE, XIANG-QUN · 2010 to 2014
$1.7M
NIDA NIH HHS P30 DA035778NIDA NIH HHS R01 DA025612
6 · The paper itself

Abstract

Drug abuse (DA) or drug addiction is a complicated brain disorder which is commonly considered as neurobiological impairments caused by both genetic factors and environmental effects. Among DA-related targets, G protein-coupled receptors (GPCRs) play an important role in DA therapy. However, only 52 GPCRs have been published with crystal structures in the recent two decades. In the effort to overcome the limitations of crystal structure and conformational diversity of GPCRs, we built homology models and performed conformational searches by molecular dynamics (MD) simulation. To accelerate and facilitate the drug abuse research, we construct a DA-related GPCR-specific chemogenomics knowledgebase (KB) (DAKB-GPCRs) for its research that can be implemented with our established and novel chemogenomics tools as well as algorithms for data analysis and visualization. Our established TargetHunter and HTDocking tools, as well as our novel tools that include target classification and Spider Plot, are compiled into the platform. Our DAKB-GPCRs provides the following results for a query compound: (1) blood-brain barrier (BBB) plot via our BBB predictor, (2) docking scores via HTDocking, (3) similarity score via TargetHunter, (4) target classification via machine learning methods that utilize both docking scores and similarity scores, and (5) a drug-target interaction network via Spider Plot.

Indexed as

Blood-Brain BarrierComputational BiologyKnowledge BasesMolecular Docking SimulationMolecular Targeted TherapyProtein ConformationReceptors, G-Protein-CoupledSubstance-Related DisordersReceptors, G-Protein-Coupled

Identifiers

PMID30835466
PMCPMC6758544
OpenAlexW2918278359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.